These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 565798)

  • 1. Cefamandole---a review of chemistry and microbiology.
    Kaiser GV; Gorman M; Webber JA
    J Infect Dis; 1978 May; 137 Suppl():S10-S16. PubMed ID: 565798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of cefamandole in vitro.
    Meyers BR; Hirschman SZ
    J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.
    Ernst EC; Berger S; Barza M; Jacobus NV; Tally FP
    Antimicrob Agents Chemother; 1976 May; 9(5):852-5. PubMed ID: 949182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests.
    Barry AL; Schoenknecht FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Antimicrob Agents Chemother; 1979 Jan; 15(1):140-1. PubMed ID: 106770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of synergism between cefamandole and gentamicin or tobramycin by the triple layer agar method with enzymatic inactivation.
    Yourassowsky E; Schoutens E; Van der Linden MP; Lismont MJ
    Infection; 1979; 7(5):237-9. PubMed ID: 389805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide.
    Counts GW; Turck M
    Antimicrob Agents Chemother; 1979 Jul; 16(1):64-8. PubMed ID: 112919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model.
    Randolph JA; Buck RE; Price KE; Leitner F
    J Antibiot (Tokyo); 1979 Jul; 32(7):727-33. PubMed ID: 396292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefamandole treatment of pulmonary infection caused by gram-negative rods.
    Mandell GL
    Scand J Infect Dis Suppl; 1980; suppl 25():107-11. PubMed ID: 7010535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
    Fu KP; Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative susceptibility of Haemophilus species to cefaclor, cefamandole, and five other cephalosporins and ampicillin, chloramphenicol, and tetracycline.
    Watanakunakorn C; Glotzbecker C
    Antimicrob Agents Chemother; 1979 Jun; 15(6):836-8. PubMed ID: 258112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1976 Apr; 9(4):690-5. PubMed ID: 1267441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formylation of glucose by cefamandole nafate at alkaline pH.
    Indelicato JM; Stewart BA; Engel GL
    J Pharm Sci; 1980 Oct; 69(10):1183-8. PubMed ID: 7420288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.
    Actor P; Uri JV; Zajac I; Guarini JR; Phillips L; Pitkin DH; Berges DA; Dunn GL; Hoover JR; Weisbach JA
    Antimicrob Agents Chemother; 1978 May; 13(5):784-90. PubMed ID: 96734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.
    Neu HC
    Antimicrob Agents Chemother; 1974 Aug; 6(2):177-82. PubMed ID: 15828189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.